Emma Elliston is an associate in the London Life Sciences practice group. She has acted for pharmaceutical companies in relation to public inquiries regarding medicinal products and product liability litigation before the UK courts. Dr. Elliston advises a broad range of clients on the pharmaceutical and medical device regulatory framework in the UK and EU, as well as the implementation of the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization. Dr. Elliston also assists with commercial transactions involved in the development and commercialisation of medicinal products, with particular experience in the drafting and negotiating of manufacturing, distribution and supply agreements.

As well as her Life Sciences practice, she is committed to pro bono work and has assisted in a range of matters against government departments and before the UK courts.

Prior to pursuing a legal career, Dr. Elliston was a scientist with a degree, Masters and PhD specialising in structural biology and biochemistry.

Experience

  • Bayer in relation to product liability claims arising out of a legacy product, Primodos, used as a hormone pregnancy test.
  • A global pharmaceutical company in a product liability public inquiry.
  • Pfizer in agreements for the supply of medicines and vaccines on a not-for-profit basis to 45 of the world’s low and lower-middle income countries as part of its Accord for a Healthier World.
  • Advising several pharmaceutical and biotech companies on the application of the Nagoya Protocol to research projects.
  • Advising a UK biotech company in a commercial services dispute, resulting in a favourable settlement for our client.
  • Advising a global biopharma company on the regulatory aspects of its acquisition of a biotech company.

Perspectives

Virtual and Digital Health Digest
BioSlice Blog
2022 EU/UK Life Sciences Future Forum Full Day Bootcamp
Arnold & Porter's Future Pharma Forum, London

Credentials

Education
  • Legal Practice Course, University of Law, 2020
  • Graduate Diploma in Law, University of Law, 2019
  • PhD, Structural, Computational and Chemical Biology, University College London, 2018
  • MBiochem, Biochemistry (Molecular and Cellular), University of Oxford, 2014
Admissions
  • England and Wales
Overview

Email Disclaimer